CXCL12 and cancer: In this study, adaption of triple-negative breast MDA-MB-231 cancer cells to the CAF-secreted factors CXCL12 and IGF1 coincided with an increase in Src activity, which was then shown to be an result of an accumulation of pre-existing cells with a hyperactive Src pathway.